Microsynth is a premier partner in therapeutic oligonucleotide synthesis, specializing in custom solutions for the discovery phase of nucleic acid-based drug development. With over three decades of expertise, we deliver innovative ASO and siRNA designs, screening oligonucleotides, and low-endotoxin materials for in vivo studies. Our tailored services support groundbreaking research and pharmaceutical innovation. With our team of more than 130 experts across Switzerland, Germany, Austria, and France, we combine quality manufacturing with advanced DNA and RNA analysis. Committed to exceptional customer service and continuous improvement, Microsynth remains at the forefront of therapeutic oligo synthesis today.